| |
| | David Coleman, M.D., Internal Medicine (Site not responding. Last check: 2007-10-31) |
 | | Coleman has a long-standing interest in the mechanisms of activation of immune cells, especially of macrophages., Dr. Coleman's laboratory research program has been closed since he assumed administrative responsibilities. |
 | | Recently, Dr. Coleman has helped to develop strategies to promote the productivity of clinicians and improve relationships between commercial entities and academic medicine. |
 | | Coleman, DL, Kazdin, AE, Miller LA, Morrow, JS, Udelsman, R. Guidelines for the Interactions between clinical faculty and the pharmaceutical industry: One medical schools approach. |
| info.med.yale.edu /intmed/infdis/pages/coleman.html (148 words) |
|